Bei Su (贝苏)贝苏
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 扬子江药业集团有限公司Chinese legal name: 扬子江药业集团有限公司
主要成分Active Ingredients
- 吗氯贝胺Malv Beian
药物知识说明
吗氯贝胺是一种在国家药监局注册认定的药品。该药品含有吗氯贝胺-3e9bac8c等成分。
该药品关联的活性成分包括：吗氯贝胺Malv Beian。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：扬子江药业集团有限公司Chinese legal name: 扬子江药业集团有限公司。
您可以探索含有相同成分的其他药品：吗氯贝胺-3e9bac8c成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 贝苏) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 吗氯贝胺Malv Beian.
Manufacturers recorded for this product: 扬子江药业集团有限公司Chinese legal name: 扬子江药业集团有限公司.
Explore other medicines containing the same ingredient: 吗氯贝胺 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 贝苏Recorded Chinese name: 贝苏
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.1g。0.1 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 扬子江药业集团有限公司Chinese legal name: 扬子江药业集团有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H19990322
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H19990322
Manufacturer
Chinese legal name: 扬子江药业集团有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H19990322
生产企业
扬子江药业集团有限公司(国产)
适应症
本品抑郁症。
用法用量
口服。开始剂量为一次50mg～100mg，一日2～3次。逐渐增加至一日150mg～450mg，高量为一日600mg。
不良反应
有轻度恶心、口干、头痛、头晕、出汗、心悸、失眠、体位性低血压等。与酪胺含量高的食物（如奶酪）同服可能引起高血压。少见不良反应有过敏性皮疹。偶见意识障碍及肝功能损害。大剂量时可能诱发癫痫。
禁忌
1. 躁狂症患者、嗜铬细胞瘤、甲状腺亢进患者禁用。 2. 对本品过敏者禁用。
注意事项
1. 肝，肾功能严重不全者慎用。 2. 本品禁止与其他抗抑郁药物同时使用，以避免引起"高5-羟色胺综合症"的危险。 3. 使用中枢性镇痛药（度冷丁，可待因，美沙芬），麻黄碱，伪麻黄碱或苯丙醇氨患者禁用本品。 4. 患者有转向躁狂发作倾向时应立即停药。 5. 用药期间不宜驾驶车辆，操作机械或高空作业。 6. 用药期间应定期检查血象，心，肝，肾功能。 7. 由其他抗抑郁药换用本品，建议停药2周后再开始使用本品;氟西汀应停药5周再开始使用本品。
贮藏
密闭保存。
规格
0.1g。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.